Weber, J., Braun, C. J., Saur, D. & Rad, R. In vivo functional screening for systems-level integrative cancer genomics. Nat. Rev. Cancer 20, 573–593 (2020).

CAS  PubMed  Article  Google Scholar 

Gilbert, L. A. & Hemann, M. T. DNA damage-mediated induction of a chemoresistant niche. Cell 143, 355–366 (2010).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bent, E. H., Gilbert, L. A. & Hemann, M. T. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev. 30, 1811–1821 (2016).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schneider, G., Schmidt-Supprian, M., Rad, R. & Saur, D. Tissue-specific tumorigenesis: context matters. Nat. Rev. Cancer 17, 239–253 (2017).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Beronja, S. et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501, 185–190 (2013).

CAS  PubMed  PubMed Central  Article  Google Scholar 

LaFleur, M. W. et al. A CRISPR–Cas9 delivery system for in vivo screening of genes in the immune system. Nat. Commun. 10, 1668 (2019).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Wuestefeld, T. et al. A direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 153, 389–401 (2013).

CAS  PubMed  Article  Google Scholar 

Rogers, Z. N. et al. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat. Methods 14, 737–742 (2017).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Braun, C. J. et al. Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation. Proc. Natl. Acad. Sci. USA. 113, E3892–E3900 (2016).

CAS  PubMed  PubMed Central  Google Scholar 

Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246–1260 (2015).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Evers, B. et al. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat. Biotechnol. 34, 631–633 (2016).

CAS  PubMed  Article  Google Scholar 

Sanson, K. R. et al. Optimized libraries for CRISPR–Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 1–15 (2018).

Article  CAS  Google Scholar 

Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096–1101 (2015).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Aguirre, A. J. et al. Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting. Cancer Discov. 6, 914–929 (2016).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Munoz, D. M. et al. CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions. Cancer Discov. 6, 900–913 (2016).

CAS  PubMed  Article  Google Scholar 

Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 (2017).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Liu, S. J. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 355, eaah7111 (2017).

Article  CAS  Google Scholar 

Zhou, H. et al. In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat. Neurosci. 21, 440–446 (2018).

CAS  PubMed  Article  Google Scholar 

Roth, T. L. et al. Pooled knockin targeting for genome engineering of cellular immunotherapies. Cell 181, 728–744.e21 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nakamura, M., Gao, Y., Dominguez, A. A. & Qi, L. S. CRISPR technologies for precise epigenome editing. Nat. Cell Biol. 23, 11–22 (2021).

CAS  PubMed  Article  Google Scholar 

Nissim, L., Perli, S. D., Fridkin, A., Perez-Pinera, P. & Lu, T. K. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol. Cell 54, 698–710 (2014).

CAS  PubMed  PubMed Central  Article  Google Scholar 

McCarty, N. S., Graham, A. E., Studená, L. & Ledesma-Amaro, R. Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat. Commun. 11, 1281 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Labuhn, M. et al. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications. Nucleic Acids Res. 46, 1375–1385 (2018).

CAS  PubMed  Article  Google Scholar 

Wessels, H.-H. et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Nat. Biotechnol. 38, 722–727 (2020).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, e19760 (2016).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Hanna, R. E. & Doench, J. G. Design and analysis of CRISPR–Cas experiments. Nat. Biotechnol. 38, 813–823 (2020).

CAS  PubMed  Article  Google Scholar 

Montague, T. G., Cruz, J. M., Gagnon, J. A., Church, G. M. & Valen, E. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 42, 401–407 (2014).

Article  CAS  Google Scholar 

Heigwer, F., Kerr, G. & Boutros, M. E-CRISP: fast CRISPR target site identification. Nat. Methods 11, 122–123 (2014).

CAS  PubMed  Article  Google Scholar 

Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR–Cas9. Nat. Biotechnol. 34, 184–191 (2016).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242–W245 (2018).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Meier, J. A., Zhang, F. & Sanjana, N. E. GUIDES: sgRNA design for loss-of-function screens. Nat. Methods 14, 831–832 (2017).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Li, F. et al. In vivo epigenetic crispr screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma. Cancer Discov. 10, 270–287 (2020).

PubMed  Article  Google Scholar 

Wu, Q. et al. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proc. Natl. Acad. Sci. USA. 115, E3978–E3986 (2018).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Michels, B. E. et al. Pooled in vitro and in vivo CRISPR–Cas9 screening identifies tumor suppressors in human colon organoids. Cell Stem Cell 26, 782–792.e7 (2020).

CAS  PubMed  Article  Google Scholar 

Becker, M. et al. CLUE: a bioinformatic and wet-lab pipeline for multiplexed cloning of custom sgRNA libraries. Nucleic Acids Res. 48, e78 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Charan, J. & Kantharia, N. D. How to calculate sample size in animal studies? J. Pharmacol. Pharmacother. 4, 303 (2013).

PubMed  PubMed Central  Article  Google Scholar 

Manguso, R. T. et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547, 413–418 (2017).

CAS  PubMed  PubMed Central  Article